Douglas Thorburn

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Paul Griffiths, Anna Stanton, Erin McCarrell et al. · The Lancet · 2011 · 390 citations · Full text

Vaccination, Mf59 Adjuvant, Transplantation +10

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

Manuel Rodríguez‐Perálvarez, Emmanuel Tsochatzis, María Carmen Naveas et al. · Journal of Hepatology · 2013 · 248 citations

Hepatology, Medicine, Pharmacology +9

The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

Douglas Thorburn, GW Curry, R. Spooner et al. · Gut · 2002 · 134 citations · Full text

Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome

Manuel Rodríguez‐Perálvarez, Giacomo Germani, Vasilios Papastergiou et al. · Journal of Hepatology · 2012 · 121 citations

Transplant Rejection, Transplantation, Hepatology +9

Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count

Manuel Rodríguez‐Perálvarez, Giacomo Germani, Emmanuel Tsochatzis et al. · Transplant International · 2012 · 60 citations